Flonase Users Seek Sanctions For Foes Of $35M Antitrust Deal
Flonase purchasers urged a Pennsylvania federal court Thursday to sanction objectors to a $35 million class action settlement of allegations that GlaxoSmithKline PLC improperly delayed market entry of a generic nasal...To view the full article, register now.
Already a subscriber? Click here to view full article